Women undergoing chemotherapy for a diagnosis of breast cancer experience a decrease in quality of life and, particularly, a reduction in cognitive function, both during and subsequent to therapy. To target the quality of life and cognitive function in pre-menopausal women undergoing chemotherapy, the authors plan to evaluate the effects of chemotherapy on cognitive function, quality of life, and fatigue. Pre-menopausal women with breast cancer receiving adjuvant or neoadjuvant chemotherapy, ...
Reports by Author
